| Financial Year |
March 31 2023 |
| Monetary Funds |
160,891,822.88 |
| Held-for-trading Financial Assets |
1,752,200.00 |
| Notes Receivable |
66,081,290.00 |
| Accounts Receivable |
144,999,439.59 |
| Advances to Suppliers |
122,647,823.49 |
| Other Receivables |
12,251,207.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
455,677,066.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,712,133.76 |
| Other Current Assets |
18,676,144.25 |
| Total Current Assets |
995,825,610.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,419,999.84 |
| Long-term Equity Investment |
20,489,890.42 |
| Investment Properties |
-- |
| Fixed Assetes |
293,837,637.47 |
| Under-construction Projects |
118,000,622.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,158,097.52 |
| R&D expenses |
-- |
| Goodwill |
7,414,276.20 |
| Long-Term Deferred and Prepaid Expenses |
20,822,932.74 |
| Deferred Income Tax Assets |
52,377,408.55 |
| Other Non-Current Assets |
2,342,648.03 |
| Sub-Total of Non-Current Assets |
715,520,971.09 |
| Total Assets |
1,711,346,581.99 |
| Short-Term Loans |
553,818,010.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,044,489.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,215,000.36 |
| Taxes Payable |
24,120,487.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,217,237.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,640,980.40 |
| Other Current Liabilities |
37,203,493.16 |
| Sub-Total of Current Liabilities |
758,868,880.77 |
| Long-term Loans |
173,778,488.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
44,267,511.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
297,020,309.65 |
| Total Liabilities |
1,055,889,190.42 |
| Paid-In Capital(Or Share Stock) |
428,144,600.00 |
| Capital Surplus |
24,123,941.68 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
34,659,400.36 |
| Minority Stockholder's Interest |
155,023,997.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
500,433,394.48 |
| Owner's Equity（Stockholder's Equity） |
655,457,391.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,711,346,581.99 |
